Adults 14 to 19, any sex, with Anxiety or Depression. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Feasibility - IP Use ProportionPrimary· Over one month
Average proportions of IP components completed out of IP components available per individual participant (IP component defined as opportunity offered to interact with the intervention - some individuals will have more opportunities offered than others due to factorial randomization)
Group
Value
95% CI
Intervention 1
0.10
± 0.17
Intervention 2
0.11
± 0.21
Intervention 3
0.10
± 0.16
Intervention 4
0.08
± 0.13
Total Sample
0.11
± 0.19
Feasibility - IP Use DaysPrimary· Over one month
Average Proportion of days IP is used per individual (number of days session accessed over total offered which is 28 days)
Group
Value
95% CI
Total Sample
0.04
± 0.06
UsabilityPrimary· 1 month
System Usability Scale, min: 0, Max: 100, higher scores mean better usability
Group
Value
95% CI
Full Sample Completing Follow-Up
77.4
± 13.6
Acceptability of the Intervention PrinciplePrimary· 1 month
Open-ended questions about whether the Discord server and the tools used were: helpful; whether it was affirming of SGM status; if timing and amount of content were appropriate, if privacy and confidentiality were maintained, and if they had any negative consequences of participation (e.g. parent questioning them )
Felt Discord Server and Tools were Helpful
Group
Value
95% CI
Full Sample Completing Follow-Up
72
Felt Content was Appropriate
Group
Value
95% CI
Full Sample Completing Follow-Up
74
Timing of Posting/Receiving Content Appropriate
Group
Value
95% CI
Full Sample Completing Follow-Up
73
Felt Affirmed (received emotional support or encouragement) about your sexuality or gender
Group
Value
95% CI
Full Sample Completing Follow-Up
73
Felt Privacy and Confidentiality were Maintained
Group
Value
95% CI
Full Sample Completing Follow-Up
74
Experienced any Negative Consequences from Participation
Group
Value
95% CI
Full Sample Completing Follow-Up
0
Help-Seeking Intention From Counselor or Therapist - TAU vs Not TAUPrimary· 1 month
single help-seeking intention ruler-based question (i.e. 'I intend to seek help from a counselor or therapist for my mental health problems' scale 1-7, a higher number signifying a higher intent to seek help
Group
Value
95% CI
Treatment as Usual (TAU)
4.00
± 1.00
Not TAU (Treatment As Usual)
3.99
± 1.30
Help-Seeking Intention From Counselor or Therapist - Intervention 1 vs. Not 1Primary· 1 month
single help-seeking intention ruler-based question (i.e. 'I intend to seek help from a counselor or therapist for my mental health problems' scale 1-7, a higher number signifying a higher intent to seek help
Group
Value
95% CI
Intervention 1
4.19
± 1.19
Not Intervention 1
3.79
± 1.36
Help-Seeking Intention From Counselor or Therapist - Intervention 2 vs. Not 2Primary· 1 month
single help-seeking intention ruler-based question (i.e. 'I intend to seek help from a counselor or therapist for my mental health problems' scale 1-7, a higher number signifying a higher intent to seek help
Group
Value
95% CI
Intervention 2
4.05
± 1.37
Not Intervention 2
3.92
± 1.21
Help-Seeking Intention From Counselor or Therapist - Intervention 3 vs. Non-3Primary· 1 month
single help-seeking intention ruler-based question (i.e. 'I intend to seek help from a counselor or therapist for my mental health problems' scale 1-7, a higher number signifying a higher intent to seek help
Group
Value
95% CI
Intervention 3
4.26
± 1.14
Not Intervention 3
3.69
± 1.39
Help-Seeking Intention From Counselor or Therapist - Intervention 4 vs. Not 4Primary· 1 month
single help-seeking intention ruler-based question (i.e. 'I intend to seek help from a counselor or therapist for my mental health problems' scale 1-7, a higher number signifying a higher intent to seek help
Group
Value
95% CI
Intervention 4
4.24
± 1.05
Not Intervention 4
3.72
± 1.47
Social Support - TAU vs Not TAUSecondary· 1 month
The Medical Outcome Study Social Support Scale measures types of social support. Per item, options range from 1 to 5 with higher levels are associated with greater support. We will use the emotional/informational subscale from this report and instead of transforming to 0-100 like the original, we will use the untransformed mean score of the items which can range 1 to 5.
Group
Value
95% CI
Treatment as Usual (TAU)
3.54
± 1.08
Not TAU (Treatment As Usual)
3.45
± 0.78
Social Support - Intervention 1 vs. Not 1Secondary· 1 month
The Medical Outcome Study Social Support Scale measures types of social support. Per item, options range from 1 to 5 with higher levels are associated with greater support. We will use the emotional/informational subscale from this report and instead of transforming to 0-100 like the original, we will use the untransformed mean score of the items which can range 1 to 5.
Group
Value
95% CI
Intervention 1
3.57
± 0.78
Not Intervention 1
3.35
± 0.78
Social Support - Intervention 2 vs. Not 2Secondary· 1 month
The Medical Outcome Study Social Support Scale measures types of social support. Per item, options range from 1 to 5 with higher levels are associated with greater support. We will use the emotional/informational subscale from this report and instead of transforming to 0-100 like the original, we will use the untransformed mean score of the items which can range 1 to 5.
Group
Value
95% CI
Intervention 2
3.41
± 0.78
Not Intervention 2
3.51
± 0.79
Sponsor's own description
the investigators will use 4 technology based tools (combinations of youtube videos, links to online resources, tiktok videos, and other media) in a study of 96 Sexual and Gender Minority Youth (SGMY) to determine the effectiveness of them in helping youth to seek out mental health help. Participants will be divided into 1 of 16 groups and will interact with other participants anonymously on Discord. Each group will have access to 1, 2, 3, or all 4 of the tools which are categorized by a specific subject (except for one group who will have no access to the tools in order to compare this outcome against those who use the tools). There will be a survey before starting the Discord portion which will last 4 weeks, and a survey afterwards.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or
· Phase 2
· recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety
· NA
· recruiting
NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients
· NA
· recruiting
NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years
· NA
· recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect
· recruiting
Other University of Pittsburgh trials
Trials by the same sponsor.
NCT05601206 — Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE
· NA
· not yet recruiting
NCT06652815 — Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation
· not yet recruiting
NCT06474286 — Prucalopride for Cognitive Functioning in Schizophrenia
· NA
· not yet recruiting
NCT06488469 — Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus
· NA
· not yet recruiting
NCT06652802 — Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pittsburgh
Last refreshed: 21 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06083987.